Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL: 2070)

Saudi Pharmaceutical Industries and Medical Appliances Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	315.47	160.07	335.35	328.32	331.07	378.97
Short-Term Investments	72	115.5	45	-	128.99	-
Trading Asset Securities	0.47	0.46	0.42	567.67	614.56	27.83
Cash & Short-Term Investments	387.94	276.03	380.77	895.99	1,075	406.8
Cash Growth	42.72%	-27.51%	-57.50%	-16.62%	164.16%	52.19%
Accounts Receivable	1,294	924.09	758.9	971.8	980.52	930.95
Other Receivables	15.79	32.82	147.12	94.29	102.88	89.05
Receivables	1,310	956.91	906.03	1,066	1,083	1,020
Inventory	523.08	589.21	494.69	419.09	458.06	409.53
Prepaid Expenses	154.05	22.98	23.73	23.99	18.6	15.47
Other Current Assets	15.39	130.17	70.56	57.16	39.87	71.59
Total Current Assets	2,391	1,975	1,876	2,462	2,675	1,923
Property, Plant & Equipment	1,851	1,838	1,829	1,818	1,827	1,720
Long-Term Investments	54.53	58.19	46.53	63.3	80.41	890.45
Other Intangible Assets	82.38	59.77	50.33	69.54	81.29	97.87
Long-Term Accounts Receivable	-	57.56	-	-	-	-
Long-Term Deferred Tax Assets	34.26	28.6	23.48	18.93	17.5	23.72
Long-Term Deferred Charges	-	6.55	6.67	1.9	1.55	-
Total Assets	4,413	4,024	3,832	4,434	4,683	4,656
Accounts Payable	401.5	333.49	223.01	303.65	345.99	403.78
Accrued Expenses	246.59	208.83	87.14	125.91	90.59	69.45
Short-Term Debt	7.2	2.05	197.32	170.15	270.17	357.78
Current Portion of Long-Term Debt	945.91	523.41	479.64	682.6	416.36	176.48
Current Portion of Leases	5.69	7.21	6.15	7.26	3.32	3.69
Current Income Taxes Payable	40.52	48.45	33.14	28.84	39.66	37.12
Other Current Liabilities	256.79	281.19	322.44	321.34	405.59	451.67
Total Current Liabilities	1,904	1,405	1,349	1,640	1,572	1,500
Long-Term Debt	529.21	575.28	379.83	417.12	649.07	663.86
Long-Term Leases	11.37	11.3	18.81	17.69	12.71	7.97
Long-Term Unearned Revenue	81.75	81.93	77.95	70.23	67.69	58.14
Total Liabilities	2,784	2,356	2,139	2,441	2,612	2,541
Common Stock	1,200	1,200	1,200	1,200	1,200	1,200
Retained Earnings	342.64	356.68	366.29	649.68	664.49	320.96
Treasury Stock	-19.16	-8	-	-	-	-
Comprensive Income & Other	-41.38	-42.03	-26.79	-11.91	51.04	422.58
Total Common Equity	1,482	1,507	1,540	1,838	1,916	1,944
Minority Interest	147.1	161.38	153.6	155.64	155.43	170.59
Shareholders' Equity	1,629	1,668	1,693	1,993	2,071	2,114
Total Liabilities & Equity	4,413	4,024	3,832	4,434	4,683	4,656
Total Debt	1,499	1,119	1,082	1,295	1,352	1,210
Net Cash (Debt)	-1,111	-843.22	-700.97	-398.82	-277.01	-802.98
Net Cash Per Share	-9.27	-7.03	-5.84	-3.32	-2.31	-6.69
Filing Date Shares Outstanding	120	120	120	120	120	120
Total Common Shares Outstanding	120	120	120	120	120	120
Working Capital	486.52	570.66	526.94	822.58	1,103	423.41
Book Value Per Share	12.35	12.56	12.83	15.31	15.96	16.20
Tangible Book Value	1,400	1,447	1,489	1,768	1,834	1,846
Tangible Book Value Per Share	11.66	12.06	12.41	14.74	15.29	15.38
Land	-	120.93	122.04	122.05	122.27	122.05
Buildings	-	1,006	772.75	776.76	776.96	696.27
Machinery	-	1,156	1,106	1,107	1,104	994.67
Construction In Progress	569.81	534	753.81	686.46	672.49	708.23

Source: S&P Capital IQ. Standard template. Financial Sources.